Aviance Capital Partners, LLC Biogen Inc. Transaction History

Aviance Capital Partners, LLC

$653 Million
Q1 2024

A detailed history of Aviance Capital Partners, LLC transactions in Biogen Inc. stock. As of the latest transaction made, Aviance Capital Partners, LLC holds 970 shares of BIIB stock, worth $221,227. This represents 0.03% of its overall portfolio holdings.

Number of Shares

970

Previous 1,030 5.83%

Holding current value

$221,227

Previous $266,000 21.43%

% of portfolio

0.03%

Previous 0.06%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 17, 2024	SELL	$212.02 - $267.71 $12,721 - $16,062	-60 Reduced 5.83%	970 $209,000
Q4 2023 Feb 06, 2024	SELL	$222.59 - $267.94 $1,112 - $1,339	-5 Reduced 0.48%	1,030 $266,000
Q2 2023 Aug 04, 2023	SELL	$275.25 - $318.06 $27,525 - $31,806	-100 Reduced 8.81%	1,035 $294,000
Q4 2022 Feb 06, 2023	SELL	$252.44 - $306.72 $12,622 - $15,336	-50 Reduced 4.22%	1,135 $314,000
Q3 2022 Nov 09, 2022	SELL	$194.69 - $268.46 $38,353 - $52,886	-197 Reduced 14.25%	1,185 $316,000

Q2 2022 Aug 08, 2022	SELL	$187.54 - $223.02 $110,648 - $131,581	-590 Reduced 29.92%	1,382 $282,000
Q1 2022 May 06, 2022	SELL	$193.77 - $244.14 $15,114 - $19,042	-78 Reduced 3.8%	1,972 $415,000
Q4 2021 Feb 07, 2022	SELL	$223.92 - $287.77 $1.98 Million - $2.55 Million	-8,849 Reduced 81.19%	2,050 $492,000
Q3 2021 Nov 12, 2021	BUY	$282.99 - $369.05 $398,732 - $519,991	1,409 Added 14.85%	10,899 $3.08 Million
Q2 2021 Aug 06, 2021	SELL	$259.0 - $414.71 $743,330 - $1.19 Million	-2,870 Reduced 23.22%	9,490 $3.29 Million
Q1 2021 Apr 29, 2021	BUY	$242.95 - $284.63 $11,904 - $13,946	49 Added 0.4%	12,360 $3.46 Million
Q4 2020 Feb 12, 2021	SELL	$236.26 - $355.63 $168,925 - $254,275	-715 Reduced 5.49%	12,311 $3.01 Million
Q3 2020 Nov 03, 2020	BUY	$264.77 - $305.71 $147,741 - $170,586	558 Added 4.48%	13,026 $3.7 Million
Q2 2020 Jul 24, 2020	BUY	$258.66 - $342.55 $102,429 - $135,649	396 Added 3.28%	12,468 $3.34 Million
Q1 2020 May 05, 2020	BUY	$268.85 - $341.04 $240,083 - $304,548	893 Added 7.99%	12,072 $3.82 Million
Q4 2019 Feb 07, 2020	SELL	$220.06 - $304.07 $880 - $1,216	-4 Reduced 0.04%	11,179 $3.32 Million
Q3 2019 Nov 07, 2019	BUY	$217.44 - $243.88 $1.14 Million - $1.28 Million	5,229 Added 87.82%	11,183 $2.6 Million
Q2 2019 Aug 12, 2019	SELL	$219.29 - $241.72 $99,119 - $109,257	-452 Reduced 7.06%	5,954 $1.39 Million
Q1 2019 May 01, 2019	BUY	$216.71 - $338.96 $120,490 - $188,461	556 Added 9.5%	6,406 $1.51 Million
Q4 2018 Feb 11, 2019	SELL	$278.5 - $352.75 $314,148 - $397,902	-1,128 Reduced 16.17%	5,850 $1.76 Million
Q3 2018 Nov 09, 2018	BUY	$293.51 - $383.83 $29,351 - $38,383	100 Added 1.45%	6,978 $2.47 Million
Q2 2018 Aug 10, 2018	BUY	$257.52 - $306.91 $782,860 - $933,006	3,040 Added 79.21%	6,878 $2 Million
Q1 2018 May 03, 2018	BUY	$260.13 - $367.91 $59,569 - $84,251	229 Added 6.35%	3,838 $1.05 Million
Q4 2017 Feb 13, 2018	SELL	$307.64 - $344.58 $43,684 - $48,930	-142 Reduced 3.79%	3,609 $1.15 Million
Q3 2017 Nov 09, 2017	BUY	$281.15 - $329.69 $1.05 Million - $1.24 Million	3,751	3,751 $1.18 Million

Others Institutions Holding BIIB

# of Institutions

1,047

Shares Held

126M

Call Options Held

1.37M

Put Options Held

1.35M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $32.8B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aviance Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aviance Capital Partners, LLC with notifications on news.

Account

Aviance Capital Partners, LLC Biogen Inc. Transaction History